Search research articles
Contact Us
Filters
Showing results (41-50 of 128) with videos related to
Page
of 13
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 18, 2010
CTLA-4 blockade following relapse of malignancy after allogeneic stem cell transplantation is associated with T cell activation but not with increased levels of T regulatory cells
Jiehua Zhou, Asad Bashey, Ruikun Zhong, et al.
Leukemia Research
|
November 24, 2005
Non-anthracycline based remission induction therapy for newly diagnosed patients with acute myeloid leukemia aged 60 or older
Asad Bashey, Lin Liu, Anita Ihasz, et al.
Bone Marrow Transplantation
|
July 31, 2024
HLA evolutionary divergence (HED) informs the effect of HLA-B mismatch on outcomes after haploidentical transplantation
Melhem Solh, Michael T Aubrey, Xu Zhang, et al.
Transplantation and Cellular Therapy
|
July 5, 2022
Lineage-Specific Relapse Prediction After Haploidentical Transplantation With Post-Transplant Cyclophosphamide Based on Recipient HLA-B-Leader Genotype and HLA-C-Group KIR Ligand
Scott R Solomon, Michael T Aubrey, Xu Zhang, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 16, 2014
Real-life experience of a brief arsenic trioxide-based consolidation chemotherapy in the management of acute promyelocytic leukemia: favorable outcomes with limited anthracycline exposure and shorter consolidation therapy
Mindy Leech, Lawrence Morris, Moishe Stewart, et al.
Transplantation and Cellular Therapy
|
April 1, 2024
Revised HLA-DP TCE-Core Permissiveness Model Better Defines Relapse Risk and Survival following Haploidentical Transplant
Scott R Solomon, Michael T Aubrey, Lizamarie Bachier-Rodriguez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 23, 2018
Selecting the Best Donor for Haploidentical Transplant: Impact of HLA, Killer Cell Immunoglobulin-Like Receptor Genotyping, and Other Clinical Variables
Scott R Solomon, Michael T Aubrey, Xu Zhang, et al.
Transfusion
|
October 26, 2007
Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage-colony-stimulating factor and granulocyte-colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantation
Asad Bashey, Michael Donohue, Lin Liu, et al.
Haematologica
|
January 28, 2017
The effect of inter-unit HLA matching in double umbilical cord blood transplantation for acute leukemia
Claudio Brunstein, Mei-Jie Zhang, Juliet Barker, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 15, 2009
Autologous hematopoietic stem cell transplantation as an intensive consolidation therapy for adult patients in remission from acute myelogenous leukemia
Andre S Jung, Peter R Holman, Januario E Castro, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 128) with videos related to
Sort By:
Page
of 13
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 18, 2010
CTLA-4 blockade following relapse of malignancy after allogeneic stem cell transplantation is associated with T cell activation but not with increased levels of T regulatory cells
Jiehua Zhou, Asad Bashey, Ruikun Zhong, et al.
Leukemia Research
|
November 24, 2005
Non-anthracycline based remission induction therapy for newly diagnosed patients with acute myeloid leukemia aged 60 or older
Asad Bashey, Lin Liu, Anita Ihasz, et al.
Bone Marrow Transplantation
|
July 31, 2024
HLA evolutionary divergence (HED) informs the effect of HLA-B mismatch on outcomes after haploidentical transplantation
Melhem Solh, Michael T Aubrey, Xu Zhang, et al.
Transplantation and Cellular Therapy
|
July 5, 2022
Lineage-Specific Relapse Prediction After Haploidentical Transplantation With Post-Transplant Cyclophosphamide Based on Recipient HLA-B-Leader Genotype and HLA-C-Group KIR Ligand
Scott R Solomon, Michael T Aubrey, Xu Zhang, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 16, 2014
Real-life experience of a brief arsenic trioxide-based consolidation chemotherapy in the management of acute promyelocytic leukemia: favorable outcomes with limited anthracycline exposure and shorter consolidation therapy
Mindy Leech, Lawrence Morris, Moishe Stewart, et al.
Transplantation and Cellular Therapy
|
April 1, 2024
Revised HLA-DP TCE-Core Permissiveness Model Better Defines Relapse Risk and Survival following Haploidentical Transplant
Scott R Solomon, Michael T Aubrey, Lizamarie Bachier-Rodriguez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 23, 2018
Selecting the Best Donor for Haploidentical Transplant: Impact of HLA, Killer Cell Immunoglobulin-Like Receptor Genotyping, and Other Clinical Variables
Scott R Solomon, Michael T Aubrey, Xu Zhang, et al.
Transfusion
|
October 26, 2007
Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage-colony-stimulating factor and granulocyte-colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantation
Asad Bashey, Michael Donohue, Lin Liu, et al.
Haematologica
|
January 28, 2017
The effect of inter-unit HLA matching in double umbilical cord blood transplantation for acute leukemia
Claudio Brunstein, Mei-Jie Zhang, Juliet Barker, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 15, 2009
Autologous hematopoietic stem cell transplantation as an intensive consolidation therapy for adult patients in remission from acute myelogenous leukemia
Andre S Jung, Peter R Holman, Januario E Castro, et al.
Page
of 13